ABRs were recorded using subdermal needle electrodes inserted at the vertex (active), ipsilateral mastoid (reference), and contralateral mastoid (ground), where the responses were amplified 10,000 , band-pass filtered from 0.3 to 3 kHz, and averaged across 512 repetitions at a rate of 21/s
monitor blood glucose
1, Table 2)
If they are willing to self-fund, self-funding SGLT-2 inhibitor ($80-100/month) is cheaper than self-funding GLP-1 agonists ($150-250/month) DPP-4 inhibitor (e.g
Retrieved 4 November 2018
however, those who persisted with the medication coverage experienced weight losses comparable with those shown in corresponding clinical trials. And in a paper published in 2023, researchers found that while significant weight loss was achievable with GLP-1s among type 2 diabetes patients, the average weight reduction was relatively modest, 2.2% after 72 weeks of being on the medications